Citations (173)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Ali S. Alqahtani, Mostafa M. Ghorab, Fahd A. Nasr, Mohammad Z. Ahmed, Abdullah A. Al-Mishari & Sabry M. Attia. (2022) Novel sulphonamide-bearing methoxyquinazolinone derivatives as anticancer and apoptosis inducers: synthesis, biological evaluation and in silico studies. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 86-99.
Read now
Read now
Farrhat F. Mohammed, Mohamad Hagar, Shazia Parveen, Rua B. Alnoman, Hoda A. Ahmed, El Sayed H. El Ashry & Hanaa A. Rasheed. (2022) 2-(Alkylthio)-3-(Naphthalen-1-yl)Quinazolin-4(3H)-Ones: Ultrasonic Synthesis, DFT and Molecular Docking Aspects. Polycyclic Aromatic Compounds 42:7, pages 4034-4048.
Read now
Read now
Marwa F. Ahmed, Eman Y. Santali & Radwan El-Haggar. (2021) Novel piperazine–chalcone hybrids and related pyrazoline analogues targeting VEGFR-2 kinase; design, synthesis, molecular docking studies, and anticancer evaluation. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 308-319.
Read now
Read now
Lina He, Fengchun Zhang, Yue Ma, Li Zuo & Yingchun Xu. (2020) Pathological Complete Response from Pyrotinib Combined with Trastuzumab, Paclitaxel and Cisplatin in a Postpartum Woman with HER2-Positive Locally Advanced Breast Cancer: A Case Report. OncoTargets and Therapy 13, pages 8749-8756.
Read now
Read now
Fatih M Uckun & Sanjive Qazi. (2010) Bruton's tyrosine kinase as a molecular target in treatment of leukemias and lymphomas as well as inflammatory disorders and autoimmunity. Expert Opinion on Therapeutic Patents 20:11, pages 1457-1470.
Read now
Read now
Bin Shi, James Hardwick, Brett Connolly, Xianzhi Mao, Rosemary McFall, Susan Hill, Kenneth A. Thomas, Nancy E. Kohl & Laura Sepp-Lorenzino. (2010) Immunohistochemical Detection of Antitumor, Antimetastasis, and Antiangiogenesis Effects of a Vascular Endothelial Growth Factor Receptor 2 Kinase Inhibitor in an Orthotopic Breast Cancer Metastasis Model. Journal of Histotechnology 33:1, pages 15-24.
Read now
Read now
Yong Jia, Xiang-ju Gu, Achim Brinker & Markus Warmuth. (2008) Measuring the tyrosine kinase activity: a review of biochemical and cellular assay technologies. Expert Opinion on Drug Discovery 3:8, pages 959-978.
Read now
Read now
Julie A Spicer. (2008) New small-molecule inhibitors of mitogen-activated protein kinase kinase. Expert Opinion on Drug Discovery 3:7, pages 801-817.
Read now
Read now
Fatih M. Uckun. (2008) Clinical Potential of Targeting Bruton's Tyrosine Kinase. International Reviews of Immunology 27:1-2, pages 43-69.
Read now
Read now
PKS Sarma, Ruchi Tandon, Praful Gupta, Sunanda G Dastidar, Abhijit Ray, Biswajit Das & Ian A Cliffe. (2007) Progress in the development of small molecule inhibitors of insulin-like growth factor-1 receptor kinase. Expert Opinion on Therapeutic Patents 17:1, pages 25-35.
Read now
Read now
Keykavous Parang & Gongqin Sun. (2005) Recent advances in the discovery of Src kinase inhibitors. Expert Opinion on Therapeutic Patents 15:9, pages 1183-1207.
Read now
Read now
Peter M Fischer & Athos Gianella-Borradori. (2005) Recent progress in the discovery and development of cyclin-dependent kinase inhibitors. Expert Opinion on Investigational Drugs 14:4, pages 457-477.
Read now
Read now
Ariane Söling & Nikolai G Rainov. (2003) Bioluminescence imaging in vivo – application to cancer research. Expert Opinion on Biological Therapy 3:7, pages 1163-1172.
Read now
Read now
Articles from other publishers (160)
Mohamed G. Abouelenein, Ahmed A. El-Rashedy, Hanem M. Awad, Ahmed F. El Farargy, Ibrahim F. Nassar & Amr Nassrallah. (2023) Synthesis, molecular modeling Insights, and anticancer assessment of novel polyfunctionalized Pyridine congeners. Bioorganic Chemistry 141, pages 106910.
Crossref
Crossref
Anupriya Bandyopadhyay, Tuyelee Das, Samapika Nandy, Synudeen Sahib, Subham Preetam, Abilash Valsala Gopalakrishnan & Abhijit Dey. (2023) Ligand-based active targeting strategies for cancer theranostics. Naunyn-Schmiedeberg's Archives of Pharmacology 396:12, pages 3417-3441.
Crossref
Crossref
María José Bravo, Antonio Manuel Burgos-Molina, Marilina García-Aranda, Maximino Redondo & Teresa Téllez. (2023) Unlocking New Avenues in Breast Cancer Treatment: The Synergy of Kinase Inhibitors and Immunotherapy. Cancers 15:23, pages 5499.
Crossref
Crossref
Archana Sharma, Diksha Sharma, Neha Saini, Sunil V. Sharma, Vijay Kumar Thakur, Ramesh K. Goyal & Prabodh Chander Sharma. (2023) Recent advances in synthetic strategies and SAR of thiazolidin-4-one containing molecules in cancer therapeutics. Cancer and Metastasis Reviews 42:3, pages 847-889.
Crossref
Crossref
Dalia H. Soliman & Mohamed S. Nafie. (2023) Design, synthesis, and docking studies of novel pyrazole-based scaffolds and their evaluation as VEGFR2 inhibitors in the treatment of prostate cancer. RSC Advances 13:30, pages 20443-20456.
Crossref
Crossref
Niloy Sarkar, Amit Singh, Pankaj Kumar & Mahima Kaushik. (2023) Protein kinases: Role of their dysregulation in carcinogenesis,
identification and inhibition. Drug Research 73:04, pages 189-199.
Crossref
Crossref
Hend A. A. Ezelarab, Taha F. S. Ali, Samar H. Abbas, Ahmed M. Sayed, Eman A. M. Beshr & Heba A. Hassan. (2023) New antiproliferative 3-substituted oxindoles inhibiting EGFR/VEGFR-2 and tubulin polymerization. Molecular Diversity.
Crossref
Crossref
Sha Yin, Yajing Chi, Yangyang Du, Jingfen Wang, Changping Shan, Weiwei Yi, Mao Shang, Xiaochu Man, Qiaorui Tan & Huihui Li. (2022) Efficacy and safety of pyrotinib‐containing regimen in the patients with HER2‐positive metastatic breast cancer: A multicenter real‐world study. Cancer Medicine 12:3, pages 2333-2344.
Crossref
Crossref
Qiyun Shi, Juncheng Xuhong, Tao Luo, Jia Ge, Feng Liu, Yang Lan, Qingqiu Chen, Peng Tang, Linjun Fan, Li Chen, Yan Liang, Minghao Wang, Ying Hu, Yi Zhang, Xiuwu Bian, Xiaowei Qi & Jun Jiang. (2022) PIK3CA mutations are associated with pathologic complete response rate to neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2-positive breast cancer. British Journal of Cancer 128:1, pages 121-129.
Crossref
Crossref
Sayed Reshad Ghafouri, Suvarna Guvvala, Catherine Jones & Alexander Philipovskiy. (2023) Recently approved treatment options for patients with metastatic triple-negative and HER2-neu-positive breast cancer. Journal of Investigative Medicine 70:6, pages 1329-1341.
Crossref
Crossref
K. Yogesh Kumar, C. B. Pradeep Kumar, K. N. N. Prasad, Byong‐Hun Jeon, Ali Alsalme & M. K. Prashanth. (2022)
Microwave‐assisted
N
‐alkylation of amines with alcohols catalyzed by MnCl
2
: Anticancer, docking, and DFT studies
. Archiv der Pharmazie 355:5, pages 2100443.
Crossref
Crossref
Yajing Chi, Mao Shang, Liang Xu, Heyi Gong, Rongjie Tao, Lihua Song, Baoxuan Zhang, Sha Yin, Binbin Cong & Huihui Li. (2022) Durable Effect of Pyrotinib and Metronomic Vinorelbine in HER2-Positive Breast Cancer With Leptomeningeal Disease: A Case Report and Literature Review. Frontiers in Oncology 12.
Crossref
Crossref
Katja Zirlik & Justus Duyster. 2020. Kompendium Internistische Onkologie. Kompendium Internistische Onkologie
1
14
.
Pei-Wen Peng, Jen-Chang Yang, Mamadi M.S Colley & Tzu-Sen Yang. (2021) An Optical Tweezers-Based Single-Cell Manipulation and Detection Platform for Probing Real-Time Cancer Cell Chemotaxis and Response to Tyrosine Kinase Inhibitor PD153035. Photonics 8:12, pages 533.
Crossref
Crossref
Jianyu Liu, Xueying Wang, Yuhan Deng, Xin Yu, Hongbin Wang & Zhigao Li. (2021) Research Progress on the Role of Regulatory T Cell in Tumor Microenvironment in the Treatment of Breast Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Adileh Ayati, Setareh Moghimi, Mahsa Toolabi & Alireza Foroumadi. (2021) Pyrimidine-based EGFR TK inhibitors in targeted cancer therapy. European Journal of Medicinal Chemistry 221, pages 113523.
Crossref
Crossref
Ahmed Elkamhawy, Usama M. Ammar, Sora Paik, Magda H. Abdellattif, Mohamed H. Elsherbeny, Kyeong Lee & Eun Joo Roh. (2021) Scaffold Repurposing of In-House Small Molecule Candidates Leads to Discovery of First-in-Class CDK-1/HER-2 Dual Inhibitors: In Vitro and In Silico Screening. Molecules 26:17, pages 5324.
Crossref
Crossref
Mojtaba Mollaei, Zuhair Mohammad Hassan, Fatemeh Khorshidi & Ladan Langroudi. (2021) Chemotherapeutic drugs: Cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells?. Translational Oncology 14:5, pages 101056.
Crossref
Crossref
Kang Cheng, Chen-Fu Liu & Guo-Wu Rao. (2021) Anti-angiogenic Agents: A Review on Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Inhibitors. Current Medicinal Chemistry 28:13, pages 2540-2564.
Crossref
Crossref
Thamer A. Alsubi, Mohamed W. Attwa, Ahmed H. Bakheit, Hany W. Darwish, Hatem A. Abuelizz & Adnan A. Kadi. (2020)
In silico
and
in vitro
metabolism of ribociclib: a mass spectrometric approach to bioactivation pathway elucidation and metabolite profiling
. RSC Advances 10:38, pages 22668-22683.
Crossref
Crossref
Adileh Ayati, Setareh Moghimi, Somayeh Salarinejad, Maliheh Safavi, Behjat Pouramiri & Alireza Foroumadi. (2020) A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy. Bioorganic Chemistry 99, pages 103811.
Crossref
Crossref
Mariana González-Medina, Filip Miljković, Gernot S. Haase, Peter Drueckes, Joerg Trappe, Stefan Laufer & Jürgen Bajorath. (2020) Promiscuity analysis of a kinase panel screen with designated p38 alpha inhibitors. European Journal of Medicinal Chemistry 187, pages 112004.
Crossref
Crossref
Heba T. Abdel‐Mohsen, Adel S. Girgis, Abeer E. E. Mahmoud, Mamdouh M. Ali & Hoda I. El Diwani. (2019) New 2,4‐disubstituted‐2‐thiopyrimidines as VEGFR‐2 inhibitors: Design, synthesis, and biological evaluation. Archiv der Pharmazie 352:11, pages 1900089.
Crossref
Crossref
Neil M. Kershaw, Dominic P. Byrne, Hollie Parsons, Neil G. Berry, David G. Fernig, Patrick A. Eyers & Richard Cosstick. (2019) Structure-based design of nucleoside-derived analogues as sulfotransferase inhibitors. RSC Advances 9:55, pages 32165-32173.
Crossref
Crossref
Zühal Kilic-Kurt, Filiz Bakar-Ates & Mehmet Bahat. (2019) N,N′-diaryl urea derivatives: Molecular docking, molecular properties prediction and anticancer evaluation. Journal of Molecular Structure 1193, pages 239-246.
Crossref
Crossref
Marine Leclerc, Laura Mezquita, Guillaume Guillebot De Nerville, Isabelle Tihy, Ines Malenica, Salem Chouaib & Fathia Mami-Chouaib. (2019) Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing. Frontiers in Immunology 10.
Crossref
Crossref
Siddharth J. Modi & Vithal M. Kulkarni. (2019) Vascular Endothelial Growth Factor Receptor (VEGFR-2)/KDR Inhibitors: Medicinal Chemistry Perspective. Medicine in Drug Discovery 2, pages 100009.
Crossref
Crossref
Rupert Handgretinger & Michaela Döring. 2019. Concise Guide to Hematology. Concise Guide to Hematology
423
461
.
Jinyun Dong, Qijing Zhang, Zengtao Wang, Guang Huang & Shaoshun Li. (2018) Recent Advances in the Development of Indazole‐based Anticancer Agents. ChemMedChem 13:15, pages 1490-1507.
Crossref
Crossref
Hsin-Pei Shih, Xiaodan Zhang & Alex M. Aronov. (2017) Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications. Nature Reviews Drug Discovery 17:1, pages 19-33.
Crossref
Crossref
Nulgumnalli Manjunathaiah Raghavendra, Divya Pingili, Sundeep Kadasi, Akhila Mettu & S.V.U.M. Prasad. (2018) Dual or multi-targeting inhibitors: The next generation anticancer agents. European Journal of Medicinal Chemistry 143, pages 1277-1300.
Crossref
Crossref
Palak K. Parikh & Manjunath D. Ghate. (2018) Recent advances in the discovery of small molecule c-Met Kinase inhibitors. European Journal of Medicinal Chemistry 143, pages 1103-1138.
Crossref
Crossref
Mahalakshmi Ramadoss & Vijayalakshmi Mahadevan. (2018) Targeting the cancer epigenome: synergistic therapy with bromodomain inhibitors. Drug Discovery Today 23:1, pages 76-89.
Crossref
Crossref
Sunghwan Kim, Benjamin A. Shoemaker, Evan E. Bolton & Stephen H. Bryant. 2018. Computational Chemogenomics. Computational Chemogenomics
63
91
.
Ahmed H. Abdelazeem, Mohammed T. El-Saadi, Eman G. Said, Bahaa G.M. Youssif, Hany A. Omar & Samir M. El-Moghazy. (2017) Novel diphenylthiazole derivatives with multi-target mechanism: Synthesis, docking study, anticancer and anti-inflammatory activities. Bioorganic Chemistry 75, pages 127-138.
Crossref
Crossref
Ashraf Khalil & Mark J. Jameson. (2017) The EGFR Inhibitor Gefitinib Enhanced the Response of Human Oral Squamous Cell Carcinoma to Cisplatin In Vitro. Drugs in R&D 17:4, pages 545-555.
Crossref
Crossref
Yeong Hoon Kim, Lokraj Bhatt, Hye-Jin Ahn, Zhaoshou Yang, Won-Kyu Lee & Ho-Woo Nam. (2017) Suppressors for Human Epidermal Growth Factor Receptor 2/4 (HER2/4): A New Family of Anti-Toxoplasmic Agents in ARPE-19 Cells. The Korean Journal of Parasitology 55:5, pages 491-503.
Crossref
Crossref
Hua-Li Qin, Jing Leng, Bahaa G. M. Youssif, Muhammad Wahab Amjad, Maria Abdul Ghafoor Raja, Muhammad Ajaz Hussain, Zahid Hussain, Syeda Naveed Kazmi & Syed Nasir Abbas Bukhari. (2017) Synthesis and mechanistic studies of curcumin analog-based oximes as potential anticancer agents. Chemical Biology & Drug Design 90:3, pages 443-449.
Crossref
Crossref
Mona A. Abdullaziz, Heba T. Abdel-Mohsen, Ahmed M. El Kerdawy, Fatma A.F. Ragab, Mamdouh M. Ali, Sherifa M. Abu-bakr, Adel S. Girgis & Hoda I. El Diwani. (2017) Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors. European Journal of Medicinal Chemistry 136, pages 315-329.
Crossref
Crossref
Nuno M Xavier. 2017. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering.
James Turkson. 2017. The Molecular Basis of Human Cancer. The Molecular Basis of Human Cancer
695
707
.
Krzysztof Kubica & Aleksander Mazurek. (2016) WEMURAFENIB JAKO SELEKTYWNY INHIBITOR KINAZY SERONINOWO-TREONINOWEJ B-RAF STOSOWANY W LECZENIU CZERNIAKA. Prospects in Pharmaceutical Sciences 14:8, pages 52-56.
Crossref
Crossref
Jin Han, Silje Henriksen, Kristin G. Nørsett, Eirik Sundby & Bård Helge Hoff. (2016) Balancing potency, metabolic stability and permeability in pyrrolopyrimidine-based EGFR inhibitors. European Journal of Medicinal Chemistry 124, pages 583-607.
Crossref
Crossref
Jussara S. MichaloskiAlexandre R. Redondo, Leila S. MagalhãesCaio C. CambuiRicardo J. Giordano. (2016) Discovery of pan-VEGF inhibitory peptides directed to the extracellular ligand-binding domains of the VEGF receptors. Science Advances 2:10.
Crossref
Crossref
İrfan Koca, Aykut Özgür, Muhammet Er, Mehmet Gümüş, Kübra Açikalin Coşkun & Yusuf Tutar. (2016) Design and synthesis of pyrimidinyl acyl thioureas as novel Hsp90 inhibitors in invasive ductal breast cancer and its bone metastasis. European Journal of Medicinal Chemistry 122, pages 280-290.
Crossref
Crossref
Galyna Ostrovska, Olga Maslova, Delian Delev, Radka Opatrilova, Peter Kuzliak & Nataliia Savytska. (2016) Effects of novel maleimide derivatives on cell cultures with different properties. Cell and Tissue Banking 17:3, pages 505-515.
Crossref
Crossref
Zhao Yang, Zheng Fang, Wei He, Zhixiang Wang, Haifeng Gan, Qitao Tian & Kai Guo. (2016) Identification of inhibitors for vascular endothelial growth factor receptor by using dynamic combinatorial chemistry. Bioorganic & Medicinal Chemistry Letters 26:7, pages 1671-1674.
Crossref
Crossref
Shoko Itakura, Susumu Hama, Ryo Matsui & Kentaro Kogure. (2016) Effective cytoplasmic release of siRNA from liposomal carriers by controlling the electrostatic interaction of siRNA with a charge-invertible peptide, in response to cytoplasmic pH. Nanoscale 8:20, pages 10649-10658.
Crossref
Crossref
Bing Sun, Xiu’e Yin, Jin Zhang, Jian Huang, Yue Xu, Furong Zhang, Jinhui Wang, Guoqing qing Wang & Chun Hu. (2015) Synthesis, characterization and biological activity of tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives as epidermal growth factor receptor inhibitors. Chemical Research in Chinese Universities 31:6, pages 936-941.
Crossref
Crossref
Rita Azevedo, José Alexandre Ferreira, Andreia Peixoto, Manuel Neves, Nuno Sousa, Aurea Lima & Lucio Lara Santos. (2015) Emerging antibody-based therapeutic strategies for bladder cancer: A systematic review. Journal of Controlled Release 214, pages 40-61.
Crossref
Crossref
Laura Marconato, Paolo Buracco & Luca Aresu. (2015) Perspectives on the design of clinical trials for targeted therapies and immunotherapy in veterinary oncology. The Veterinary Journal 205:2, pages 238-243.
Crossref
Crossref
Anand Balupuri, Pavithra K. Balasubramanian & Seung Joo Cho. (2015) 3D-QSAR study of tetrahydro-3H-imidazo[4,5-c]pyridine derivatives as VEGFR-2 kinase inhibitors using various charge schemes. Archives of Pharmacal Research 38:8, pages 1434-1442.
Crossref
Crossref
Shalini Bajaj, Vivek Asati, Jagadish Singh & Partha Pratim Roy. (2015) 1,3,4-Oxadiazoles: An emerging scaffold to target growth factors, enzymes and kinases as anticancer agents. European Journal of Medicinal Chemistry 97, pages 124-141.
Crossref
Crossref
Steffen Bugge, Ingri Ullestad Moen, Kent-Ove Kragseth Sylte, Eirik Sundby & Bård Helge Hoff. (2015) Truncated structures used in search for new lead compounds and in a retrospective analysis of thienopyrimidine-based EGFR inhibitors. European Journal of Medicinal Chemistry 94, pages 175-194.
Crossref
Crossref
Jennifer L. Woodring, Gautam Patel, Jessey Erath, Ranjan Behera, Patricia J. Lee, Susan E. Leed, Ana Rodriguez, Richard J. Sciotti, Kojo Mensa-Wilmot & Michael P. Pollastri. (2015) Evaluation of aromatic 6-substituted thienopyrimidines as scaffolds against parasites that cause trypanosomiasis, leishmaniasis, and malaria. MedChemComm 6:2, pages 339-346.
Crossref
Crossref
Anna Spina, Valeria De Pasquale, Giuliana Cerulo, Pasquale Cocchiaro, Rossella Della Morte, Luigi Avallone & Luigi Pavone. (2015) HGF/c-MET Axis in Tumor Microenvironment and Metastasis Formation. Biomedicines 3:1, pages 71-88.
Crossref
Crossref
Gabriela Souza Fernandes, Michelle Bueno de Moura Pereira, Ana Cláudia Barbosa Marinho, Brisa Machado, Ana Carla Moreira, Matheus Puggina de Freitas, Karen Luise Lang & João Eustáquio Antunes. (2015) In <i>Silico</i> Pharmacokinetics Studies for Quinazolines Proposed as EGFR Inhibitors. Open Journal of Medicinal Chemistry 05:04, pages 106-115.
Crossref
Crossref
Maria Vergoulidou. (2015) More than a Decade of Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors: What We Have Learned and What the Future Holds. Biomarker Insights 10s3, pages BMI.S22436.
Crossref
Crossref
Xi Zong, Jin Cai, Junqing Chen, Chunlong Sun, Lushen Li & Min Ji. (2015) Discovery of 3,3a,4,5-tetrahydro-2H-benzo[g]indazole containing quinoxaline derivatives as novel EGFR/HER-2 dual inhibitors. RSC Advances 5:32, pages 24814-24823.
Crossref
Crossref
X. Li, H. Miao, Y. Zhang, W. Li, Z. Li, Y. Zhou, L. Zhao & Q. Guo. (2014) Bone marrow microenvironment confers imatinib resistance to chronic myelogenous leukemia and oroxylin A reverses the resistance by suppressing Stat3 pathway. Archives of Toxicology 89:1, pages 121-136.
Crossref
Crossref
Aifeng Lyu, Lei Fang & Shaohua Gou. (2014) Design and synthesis of Lapatinib derivatives containing a branched side chain as HER1/HER2 targeting antitumor drug candidates. European Journal of Medicinal Chemistry 87, pages 631-642.
Crossref
Crossref
Svein Jacob Kaspersen, Jin Han, Kristin G. Nørsett, Line Rydså, Eli Kjøbli, Steffen Bugge, Geir Bjørkøy, Eirik Sundby & Bård Helge Hoff. (2014) Identification of new 4-N-substituted 6-aryl-7H-pyrrolo[2,3-d]pyrimidine-4-amines as highly potent EGFR-TK inhibitors with Src-family activity. European Journal of Pharmaceutical Sciences 59, pages 69-82.
Crossref
Crossref
Byung Sun Park, Mohammad M. Al-Sanea, Ahmed Z. Abdelazem, Hye Mi Park, Eun Joo Roh, Hyun-Mee Park, Kyung Ho Yoo, Taebo Sim, Jin Sung Tae & So Ha Lee. (2014) Structure-based optimization and biological evaluation of trisubstituted pyrazole as a core structure of potent ROS1 kinase inhibitors. Bioorganic & Medicinal Chemistry 22:15, pages 3871-3878.
Crossref
Crossref
Xin Zhang, Sudhir Raghavan, Michael Ihnat, Jessica E. Thorpe, Bryan C. Disch, Anja Bastian, Lora C. Bailey-Downs, Nicholas F. Dybdal-Hargreaves, Cristina C. Rohena, Ernest Hamel, Susan L. Mooberry & Aleem Gangjee. (2014) The design and discovery of water soluble 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multitargeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agents. Bioorganic & Medicinal Chemistry 22:14, pages 3753-3772.
Crossref
Crossref
Fathia Zaky El Sharkawi, Hany Abdelaziz El Shemy & Hussein Moustafa Khaled. (2014) Possible Anticancer Activity of Rosuvastatine, Doxazosin, Repaglinide and Oxcarbazepin. Asian Pacific Journal of Cancer Prevention 15:1, pages 199-203.
Crossref
Crossref
John Watson, Brian J. Arey & Andrew Alt. 2014. Biased Signaling in Physiology, Pharmacology and Therapeutics. Biased Signaling in Physiology, Pharmacology and Therapeutics
137
172
.
Yu-Cheng Hsiao, Chen-Yu Lee, Yi-Jhen Lin, Shu-Huai Tsai, Kee-Ching G. Jeng, Wei-Ting Chao & Feng-Di T. Lung. (2013) Design, synthesis, and evaluation of fluorescent cell-penetrating peptidic antagonists of Grb2-SH2 for targeting MCF-7 breast cancer cells. Medicinal Chemistry Research 22:11, pages 5337-5343.
Crossref
Crossref
György Várady, Judit Cserepes, Adrienn Németh, Edit Szabó & Balázs Sarkadi. (2013) Cell surface membrane proteins as personalized biomarkers: where we stand and where we are headed. Biomarkers in Medicine 7:5, pages 803-819.
Crossref
Crossref
Sandip B. Bharate, Sanghapal D. Sawant, Parvinder Pal Singh & Ram A. Vishwakarma. (2013) Kinase Inhibitors of Marine Origin. Chemical Reviews 113:8, pages 6761-6815.
Crossref
Crossref
Dong-Dong Li, Ya-Juan Qin, Jian Sun, Jing-Ran Li, Fei Fang, Qian-Ru Du, Yong Qian, Hai-Bin Gong & Hai-Liang Zhu. (2013) Optimization of Substituted 6-Salicyl-4-Anilinoquinazoline Derivatives as Dual EGFR/HER2 Tyrosine Kinase Inhibitors. PLoS ONE 8:8, pages e69427.
Crossref
Crossref
Marina Bury, Anna Andolfi, Bernard Rogister, Alessio Cimmino, Véronique Mégalizzi, Véronique Mathieu, Olivier Feron, Antonio Evidente & Robert Kiss. (2013) Fusicoccin A, a Phytotoxic Carbotricyclic Diterpene Glucoside of Fungal Origin, Reduces Proliferation and Invasion of Glioblastoma Cells by Targeting Multiple Tyrosine Kinases. Translational Oncology 6:2, pages 112-123.
Crossref
Crossref
Youichi Kawakita, Masaki Seto, Tomohiro Ohashi, Toshiya Tamura, Tadashi Yusa, Hiroshi Miki, Hidehisa Iwata, Hidenori Kamiguchi, Toshimasa Tanaka, Satoshi Sogabe, Yoshikazu Ohta & Tomoyasu Ishikawa. (2013) Design and synthesis of novel pyrimido[4,5- b ]azepine derivatives as HER2/EGFR dual inhibitors. Bioorganic & Medicinal Chemistry 21:8, pages 2250-2261.
Crossref
Crossref
Mao Zhang, Xiang Lu, Hong-Jia Zhang, Na Li, Yu Xiao, Hai-Liang Zhu & Yong-Hao Ye. (2012) Synthesis, structure, and biological assay of cinnamic amides as potential EGFR kinase inhibitors. Medicinal Chemistry Research 22:2, pages 986-994.
Crossref
Crossref
Inken Wierstra. 2013.
191
419
.
Shaojing Hu, Guojian Xie, Don X. Zhang, Charles Davis, Wei Long, Yunyan Hu, Fei Wang, Xinshan Kang, Fenlai Tan, Lieming Ding & Yinxiang Wang. (2012) Synthesis and biological evaluation of crown ether fused quinazoline analogues as potent EGFR inhibitors. Bioorganic & Medicinal Chemistry Letters 22:19, pages 6301-6305.
Crossref
Crossref
Youichi Kawakita, Kazuhiro Miwa, Masaki Seto, Hiroshi Banno, Yoshikazu Ohta, Toshiya Tamura, Tadashi Yusa, Hiroshi Miki, Hidenori Kamiguchi, Yukihiro Ikeda, Toshimasa Tanaka, Keiji Kamiyama & Tomoyasu Ishikawa. (2012) Design and synthesis of pyrrolo[3,2-d]pyrimidine HER2/EGFR dual inhibitors: Improvement of the physicochemical and pharmacokinetic profiles for potent in vivo anti-tumor efficacy. Bioorganic & Medicinal Chemistry 20:20, pages 6171-6180.
Crossref
Crossref
Ning Ding, Wei Zhang, Hua Ling Xiao, Peng Wang & Ying Xia Li. (2012) Synthesis and biological evaluation of a series of novel salicylanilides as inhibitors of EGFR protein tyrosine kinases. Chinese Chemical Letters 23:5, pages 529-532.
Crossref
Crossref
Youichi Kawakita, Hiroshi Banno, Tomohiro Ohashi, Toshiya Tamura, Tadashi Yusa, Akiko Nakayama, Hiroshi Miki, Hidehisa Iwata, Hidenori Kamiguchi, Toshimasa Tanaka, Noriyuki Habuka, Satoshi Sogabe, Yoshikazu Ohta & Tomoyasu Ishikawa. (2012)
Design and Synthesis of Pyrrolo[3,2-
d
]pyrimidine Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors: Exploration of Novel Back-Pocket Binders
. Journal of Medicinal Chemistry 55:8, pages 3975-3991.
Crossref
Crossref
Sun-Young Han, Jie Won Choi, Jeon Yang, Chong Hack Chae, Jongkook Lee, Heejung Jung, Kwangho Lee, Jae Du Ha, Hyoung Rae Kim & Sung Yun Cho. (2012) Design and synthesis of 3-(4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-quinolin-2-ones as VEGFR-2 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 22:8, pages 2837-2842.
Crossref
Crossref
Isil Altintas, Robbert Jan Kok & Raymond M. Schiffelers. (2012) Targeting epidermal growth factor receptor in tumors: From conventional monoclonal antibodies via heavy chain-only antibodies to nanobodies. European Journal of Pharmaceutical Sciences 45:4, pages 399-407.
Crossref
Crossref
Kamelia El-mahdy & Reda Abdel-Rahman. (2012) Biological Evaluation of Pyrimidopyrimidines as Multi-Targeted Small Molecule Inhibitors and Resistance Modifying Agents. HETEROCYCLES 85:10, pages 2391.
Crossref
Crossref
Tomoyasu Ishikawa, Masaki Seto, Hiroshi Banno, Youichi Kawakita, Mami Oorui, Takahiko Taniguchi, Yoshikazu Ohta, Toshiya Tamura, Akiko Nakayama, Hiroshi Miki, Hidenori Kamiguchi, Toshimasa Tanaka, Noriyuki Habuka, Satoshi Sogabe, Jason Yano, Kathleen Aertgeerts & Keiji Kamiyama. (2011)
Design and Synthesis of Novel Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors Bearing a Pyrrolo[3,2-
d
]pyrimidine Scaffold
. Journal of Medicinal Chemistry 54:23, pages 8030-8050.
Crossref
Crossref
Svein Jacob Kaspersen, Christopher Sørum, Veronica Willassen, Erik Fuglseth, Eli Kjøbli, Geir Bjørkøy, Eirik Sundby & Bård Helge Hoff. (2011) Synthesis and in vitro EGFR (ErbB1) tyrosine kinase inhibitory activity of 4-N-substituted 6-aryl-7H-pyrrolo[2,3-d]pyrimidine-4-amines. European Journal of Medicinal Chemistry 46:12, pages 6002-6014.
Crossref
Crossref
Scott B. Ficarro, Yi Zhang, Marlene J. Carrasco-Alfonso, Brijesh Garg, Guillaume Adelmant, James T. Webber, C. John Luckey & Jarrod A. Marto. (2011) Online Nanoflow Multidimensional Fractionation for High Efficiency Phosphopeptide Analysis. Molecular & Cellular Proteomics 10:11, pages O111.011064.
Crossref
Crossref
Keila E. Torres, Jun Liu, Eric Young, Kai-Lieh Huang, Markus Ghadimi, Kristelle Lusby, Alexander J. Lazar & Dina Lev. (2011) Expression of ‘drugable’ tyrosine kinase receptors in malignant peripheral nerve sheath tumour: potential molecular therapeutic targets for a chemoresistant cancer. Histopathology 59:1, pages 156-159.
Crossref
Crossref
Valentina Fodale, Mariaelena Pierobon, Lance Liotta & Emanuel Petricoin. (2011) Mechanism of Cell Adaptation. The Cancer Journal 17:2, pages 89-95.
Crossref
Crossref
Shenlin Huang, Ronghua Li, Kenneth R. LaMontagne, Lee M. Greenberger & Peter J. Connolly. (2011) 4-Aminopyrimidine-5-carbaldehyde oximes as potent VEGFR-2 inhibitors. Part II. Bioorganic & Medicinal Chemistry Letters 21:6, pages 1815-1818.
Crossref
Crossref
Karen Gómez, Jeena Varghese & Camilo Jiménez. (2011) Medullary Thyroid Carcinoma: Molecular Signaling Pathways and Emerging Therapies. Journal of Thyroid Research 2011, pages 1-10.
Crossref
Crossref
Daanish Hoda & Adil Daud. 2011. Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures. Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures
319
330
.
Kyungik Lee, Ki-Woong Jeong, Yeonjoo Lee, Ji Yeon Song, Maeng Sup Kim, Gwan Sun Lee & Yangmee Kim. (2010) Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors. European Journal of Medicinal Chemistry 45:11, pages 5420-5427.
Crossref
Crossref
Shayne Cox GadIoannis S. Vizirianakis. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Shayne Cox GadKeykavous Parang & Gongqin Sun. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Rajeev S. Bhide, Louis J. Lombardo, John T. Hunt, Zhen-wei Cai, Joel C. Barrish, Susan Galbraith, Robert JeyaseelanSr.Sr., Steven Mortillo, Barri S. Wautlet, Bala Krishnan, Daniel Kukral, Harold Malone, Anne C. Lewin, Benjamin J. Henley & Joseph Fargnoli. (2010) The Antiangiogenic Activity in Xenograft Models of Brivanib, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Kinases. Molecular Cancer Therapeutics 9:2, pages 369-378.
Crossref
Crossref
Michele Milella, Ludovica Ciuffreda & Emilio Bria. 2010. Macromolecular Anticancer Therapeutics. Macromolecular Anticancer Therapeutics
37
83
.
Kazuki Inamori, Motoki Kyo, Kazuki Matsukawa, Yusuke Inoue, Tatsuhiko Sonoda, Takeshi Mori, Takuro Niidome & Yoshiki Katayama. (2009) Establishment of screening system toward discovery of kinase inhibitors using label-free on-chip phosphorylation assays. Biosystems 97:3, pages 179-185.
Crossref
Crossref
Lutz Ackermann, Sebastian Barfüßer & Harish K. Potukuchi. (2009)
Copper-Catalyzed
N
-Arylation/Hydroamin(d)ation Domino Synthesis of Indoles and its Application to the Preparation of a Chek1/KDR Kinase Inhibitor Pharmacophore
. Advanced Synthesis & Catalysis 351:7-8, pages 1064-1072.
Crossref
Crossref
Ronghui Lin, Sigmond G. Johnson, Peter J. Connolly, Steven K. Wetter, Eva Binnun, Terry V. Hughes, William V. Murray, Niranjan B. Pandey, Sandra J. Moreno-Mazza, Mary Adams, Angel R. Fuentes-Pesquera & Steven A. Middleton. (2009) Synthesis and evaluation of 2,7-diamino-thiazolo[4,5-d] pyrimidine analogues as anti-tumor epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 19:8, pages 2333-2337.
Crossref
Crossref
Antonio G. Tristano. (2009) Tyrosine kinases as targets in rheumatoid arthritis. International Immunopharmacology 9:1, pages 1-9.
Crossref
Crossref
Benjamin M. Johnson, Amrita V. Kamath, John E. Leet, Xiaohong Liu, Rajeev S. Bhide, Ravindra W. Tejwani, Yueping Zhang, Ligang Qian, Donna D. Wei, Louis J. Lombardo & Yue-Zhong Shu. (2008)
Metabolism of 5-Isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-
N
-(2-methyl-1
H
-pyrrolo[2,3-
b
]pyridin-5-yl)pyrrolo[2,1-
f
][1,2,4]triazin-4-amine (BMS-645737): Identification of an Unusual
N
-Acetylglucosamine Conjugate in the Cynomolgus Monkey
. Drug Metabolism and Disposition 36:12, pages 2475-2483.
Crossref
Crossref
Sofi Forsberg, Arne Östman & Ola Rollman. (2008) Regeneration of human epidermis on acellular dermis is impeded by small-molecule inhibitors of EGF receptor tyrosine kinase. Archives of Dermatological Research 300:9, pages 505-516.
Crossref
Crossref
Atsushi Kosaihira & Toshihiro Ona. (2008) Rapid and quantitative method for evaluating the personal therapeutic potential of cancer drugs. Analytical and Bioanalytical Chemistry 391:5, pages 1889-1897.
Crossref
Crossref
Rafael Gozalbes, Laurence Simon, Nicolas Froloff, Eric Sartori, Claude Monteils & Romuald Baudelle. (2008) Development and Experimental Validation of a Docking Strategy for the Generation of Kinase-Targeted Libraries. Journal of Medicinal Chemistry 51:11, pages 3124-3132.
Crossref
Crossref
Réjean Ruel, Carl Thibeault, Alexandre L’Heureux, Alain Martel, Zhen-Wei Cai, Donna Wei, Ligang Qian, Joel C. Barrish, Arvind Mathur, Celia D’Arienzo, John T. Hunt, Amrita Kamath, Punit Marathe, Yueping Zhang, George Derbin, Barri Wautlet, Steven Mortillo, Robert JeyaseelanSr.Sr., Benjamin Henley, Ravindra Tejwani, Rajeev S. Bhide, George L. Trainor, Joseph Fargnoli & Louis J. Lombardo. (2008) Discovery and preclinical studies of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737), an in vivo active potent VEGFR-2 inhibitor. Bioorganic & Medicinal Chemistry Letters 18:9, pages 2985-2989.
Crossref
Crossref
Tona M. Gilmer, Louann Cable, Krystal Alligood, David Rusnak, Glenn Spehar, Kathleen T. Gallagher, Ermias Woldu, H. Luke Carter, Anne T. Truesdale, Lisa Shewchuk & Edgar R. Wood. (2008) Impact of Common Epidermal Growth Factor Receptor and HER2 Variants on Receptor Activity and Inhibition by Lapatinib. Cancer Research 68:2, pages 571-579.
Crossref
Crossref
Corrine J Porter, Jacqueline M Matthews, Joel P Mackay, Sharon E Pursglove, Jason W Schmidberger, Peter J Leedman, Stephanie C Pero, David N Krag, Matthew CJ Wilce & Jacqueline A Wilce. (2007) Grb7 SH2 domain structure and interactions with a cyclic peptide inhibitor of cancer cell migration and proliferation. BMC Structural Biology 7:1.
Crossref
Crossref
Michelle D. Williams, Dianna Roberts, George R. Blumenschein, Stephane Temam, Merrill S. Kies, David I. Rosenthal, Randal S. Weber & Adel K. El-Naggar. (2007) Differential Expression of Hormonal and Growth Factor Receptors in Salivary Duct Carcinomas. American Journal of Surgical Pathology 31:11, pages 1645-1652.
Crossref
Crossref
Lee Tai Liu, Ta-Tung Yuan, Hung-Huang Liu, Shyh-Fong Chen & Ying-Ta Wu. (2007) Synthesis and biological evaluation of substituted 6-alkynyl-4-anilinoquinazoline derivatives as potent EGFR inhibitors. Bioorganic & Medicinal Chemistry Letters 17:22, pages 6373-6377.
Crossref
Crossref
Fernanda Ludolf, Diana Bahia, Luiza F. Andrade, Alexandre Cousin, Monique Capron, Colette Dissous, Raymond J. Pierce & Guilherme Oliveira. (2007) Molecular analysis of SmFes, a tyrosine kinase of Schistosoma mansoni orthologous to the members of the Fes/Fps/Fer family. Biochemical and Biophysical Research Communications 360:1, pages 163-172.
Crossref
Crossref
Shenlin Huang, Ronghua Li, Peter J. Connolly, Stuart Emanuel, Angel Fuentes-Pesquera, Mary Adams, Robert H. Gruninger, Jabed Seraj, Steven A. Middleton, Jeremy M. Davis & David F.C. Moffat. (2007) Synthesis and biological study of 2-amino-4-aryl-5-chloropyrimidine analogues as inhibitors of VEGFR-2 and cyclin dependent kinase 1 (CDK1). Bioorganic & Medicinal Chemistry Letters 17:8, pages 2179-2183.
Crossref
Crossref
Yuan-Qing Fang, Robert Karisch & Mark Lautens. (2007) Efficient Syntheses of KDR Kinase Inhibitors Using a Pd-Catalyzed Tandem C−N/Suzuki Coupling as the Key Step. The Journal of Organic Chemistry 72:4, pages 1341-1346.
Crossref
Crossref
Rachel E. Pollard, Amy R. Broumas, Erik R. Wisner, Sylvia V. Vekich & Katherine W. Ferrara. (2007) Quantitative contrast enhanced ultrasound and ct assessment of tumor response to antiangiogenic therapy in rats. Ultrasound in Medicine & Biology 33:2, pages 235-245.
Crossref
Crossref
Ioannis S Vizirianakis. (2007) Clinical Translation of Genotyping and Haplotyping Data. Clinical Pharmacokinetics 46:10, pages 807-824.
Crossref
Crossref
Veronica A. Stevens, Sonia Saad, Xin-Ming Chen & Carol A. Pollock. (2007) The interdependence of EGF-R and SGK-1 in fibronectin expression in primary kidney cortical fibroblast cells. The International Journal of Biochemistry & Cell Biology 39:5, pages 1047-1054.
Crossref
Crossref
James A. McCubrey, Linda S. Steelman, Richard A. Franklin, Steven L. Abrams, William H. Chappell, Ellis W.T. Wong, Brian D. Lehmann, David M. Terrian, Jorg Basecke, Franca Stivala, Massimo Libra, Camilla Evangelisti & Alberto M. Martelli. (2007) Targeting the RAF/MEK/ERK, PI3K/AKT and P53 pathways in hematopoietic drug resistance. Advances in Enzyme Regulation 47:1, pages 64-103.
Crossref
Crossref
S. L. Perkins & S. W. Morris. 2007. Pediatric Lymphomas. Pediatric Lymphomas
91
140
.
Nancy E. Hynes. 2007. Targeted Interference with Signal Transduction Events. Targeted Interference with Signal Transduction Events
45
57
.
Shenlin Huang, Ronghua Li, Peter J. Connolly, Guozhang Xu, Michael D. Gaul, Stuart L. Emanuel, Kenneth R. LaMontagne & Lee M. Greenberger. (2006) Synthesis and biological study of 4-aminopyrimidine-5-carboxaldehyde oximes as antiproliferative VEGFR-2 inhibitors. Bioorganic & Medicinal Chemistry Letters 16:23, pages 6063-6066.
Crossref
Crossref
Diana Bahia, Luiza Freire Andrade, Fernanda Ludolf, Renato Arruda Mortara & Guilherme Oliveira. (2006) Protein tyrosine kinases in Schistosoma mansoni. Memórias do Instituto Oswaldo Cruz 101:suppl 1, pages 137-143.
Crossref
Crossref
Seungchan Yang, Shimian Qu, Marianela Perez-Tores, Ayana Sawai, Neal Rosen, David B. Solit & Carlos L. Arteaga. (2006) Association with HSP90 Inhibits Cbl-Mediated Down-regulation of Mutant Epidermal Growth Factor Receptors. Cancer Research 66:14, pages 6990-6997.
Crossref
Crossref
Gerhard S. Mundinger, Virginia Espina, Lance A. Liotta, Emanuel F. PetricoinIIIIII & Katherine R. Calvo. (2006) Clinical phosphoproteomic profiling for personalized targeted medicine using reverse phase protein microarray. Targeted Oncology 1:3.
Crossref
Crossref
Rajeev S. Bhide, Zhen-Wei Cai, Yong-Zheng Zhang, Ligang Qian, Donna Wei, Stephanie Barbosa, Louis J. Lombardo, Robert M. Borzilleri, Xiaoping Zheng, Laurence I. Wu, Joel C. Barrish, Soong-Hoon Kim, Kenneth Leavitt, Arvind Mathur, Leslie Leith, Sam Chao, Barri Wautlet, Steven Mortillo, Robert Jeyaseelan, Daniel Kukral, John T. Hunt, Amrita Kamath, Aberra Fura, Viral Vyas, Punit Marathe, Celia D'Arienzo, George Derbin & Joseph Fargnoli. (2006)
Discovery and Preclinical Studies of (
R
)-1-(4-(4-Fluoro-2-methyl-1
H
-indol-5-yloxy)-5- methylpyrrolo[2,1-
f
][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an In Vivo Active Potent VEGFR-2 Inhibitor
. Journal of Medicinal Chemistry 49:7, pages 2143-2146.
Crossref
Crossref
Kelly Frazier, Elisa Jazan, Christopher M. McBride, Sabina Pecchi, Paul A. Renhowe, Cynthia M. Shafer, Clarke Taylor, Dirksen Bussiere, Molly Min He, Johanna M. Jansen, Gena Lapointe, Sylvia Ma, Jayesh Vora & Marion Wiesmann. (2006) Design and structure–activity relationship of heterocyclic analogs of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones as inhibitors of receptor tyrosine kinases. Bioorganic & Medicinal Chemistry Letters 16:8, pages 2247-2251.
Crossref
Crossref
Lee A. McDermott, Brian Higgins, Mary Simcox, Kin-Chun Luk, Tom Nevins, Kenneth Kolinsky, Melissa Smith, Hong Yang, Jia K. Li, Yingsi Chen, June Ke, Navita Mallalieu, Tom Egan, Stan Kolis, Aruna Railkar, Louise Gerber, Jin-Jun Liu, Fred Konzelmann, Zhuming Zhang, Tom Flynn, Omar Morales & Yi Chen. (2006) Biological evaluation of a multi-targeted small molecule inhibitor of tumor-induced angiogenesis. Bioorganic & Medicinal Chemistry Letters 16:7, pages 1950-1953.
Crossref
Crossref
Ian M. Adcock, K. Fan Chung, Gaetano Caramori & Kazuhiro Ito. (2006) RETRACTED: Kinase inhibitors and airway inflammation. European Journal of Pharmacology 533:1-3, pages 118-132.
Crossref
Crossref
Kee-In Lee, Youmie Park, Su-Jin Park, Jung-Hwan Hwang, Sung-Jin Lee, Gun-Do Kim, Woo-Kyu Park, Sunghou Lee, Daeyoung Jeong, Jae-Yang Kong, Hee-Kyoung Kang & Heeyeong Cho. (2006) Naphthofuroquinone derivatives: Inhibition of receptor tyrosine kinases. Bioorganic & Medicinal Chemistry Letters 16:3, pages 737-742.
Crossref
Crossref
Huchen Zhou, De-an Wang, Laura Baldini, Eileen Ennis, Rishi Jain, Adam Carie, Saïd M. Sebti & Andrew D. Hamilton. (2006) Structure–activity studies on a library of potent calix[4]arene-based PDGF antagonists that inhibit PDGF-stimulated PDGFR tyrosine phosphorylation. Org. Biomol. Chem. 4:12, pages 2376-2386.
Crossref
Crossref
William R. Antonios-McCrea, Kelly A. Frazier, Elisa M. Jazan, Timothy D. Machajewski, Christopher M. McBride, Sabina Pecchi, Paul A. Renhowe, Cynthia M. Shafer & Clarke Taylor. (2006) LHMDS mediated tandem acylation–cyclization of 2-aminobenzenecarbonitriles with 2-benzymidazol-2-yl acetates: a short and efficient route to the synthesis of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones. Tetrahedron Letters 47:5, pages 657-660.
Crossref
Crossref
Theresa Mikalsen, Nancy Gerits & Ugo Moens. 2006.
153
223
.
Eli M. Wallace, Tammie C. Yeh, Ellen R. Laird, James F. Blake & Joseph Lyssikatos. 2007. Cancer. Cancer
83
132
.
Yi Jin, Hui-Yuan Li, Li-Ping Lin, Jinzhi Tan, Jian Ding, Xiaomin Luo & Ya-Qiu Long. (2005) Synthesis and antitumor evaluation of novel 5-substituted-4-hydroxy-8-nitroquinazolines as EGFR signaling-targeted inhibitors. Bioorganic & Medicinal Chemistry 13:19, pages 5613-5622.
Crossref
Crossref
Matthew C. Holley. (2005) Keynote review: The auditory system, hearing loss and potential targets for drug development. Drug Discovery Today 10:19, pages 1269-1282.
Crossref
Crossref
SONIA Saad, Veronica A. Stevens, Lesley Wassef, Philip Poronnik, Darren J. Kelly, Richard E. Gilbert & Carol A. Pollock. (2005) High glucose transactivates the EGF receptor and up-regulates serum glucocorticoid kinase in the proximal tubule. Kidney International 68:3, pages 985-997.
Crossref
Crossref
Lee A. McDermott, Mary Simcox, Brian Higgins, Tom Nevins, Kenneth Kolinsky, Melissa Smith, Hong Yang, Jia K. Li, Yingsi Chen, June Ke, Navita Mallalieu, Tom Egan, Stan Kolis, Aruna Railkar, Louise Gerber & Kin-Chun Luk. (2005) RO4383596, an orally active KDR, FGFR, and PDGFR inhibitor: Synthesis and biological evaluation. Bioorganic & Medicinal Chemistry 13:16, pages 4835-4841.
Crossref
Crossref
Robert M. Borzilleri, Xiaoping Zheng, Ligang Qian, Christopher Ellis, Zhen-wei Cai, Barri S. Wautlet, Steve Mortillo, Robert Jeyaseelan,, Daniel W. Kukral, Aberra Fura, Amrita Kamath, Viral Vyas, John S. Tokarski, Joel C. Barrish, John T. Hunt, Louis J. Lombardo, Joseph Fargnoli & Rajeev S. Bhide. (2005)
Design, Synthesis, and Evaluation of Orally Active 4-(2,4-Difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-
f
][1,2,4]triazines as Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Inhibitors
. Journal of Medicinal Chemistry 48:12, pages 3991-4008.
Crossref
Crossref
Nancy E. Hynes & Heidi A. Lane. (2005) ERBB receptors and cancer: the complexity of targeted inhibitors. Nature Reviews Cancer 5:5, pages 341-354.
Crossref
Crossref
Martin F. Aguero, Maria M. Facchinetti, Zhanna Sheleg & Adrian M. Senderowicz. (2005) Phenoxodiol, a Novel Isoflavone, Induces G1 Arrest by Specific Loss in Cyclin-Dependent Kinase 2 Activity by p53-Independent Induction of p21WAF1/CIP1. Cancer Research 65:8, pages 3364-3373.
Crossref
Crossref
Jeffrey T. Kuethe, Audrey Wong, Chuanxing Qu, Jacqueline Smitrovich, Ian W. Davies & David L. Hughes. (2005)
Synthesis of 5-Substituted-1
H
-indol-2-yl-1
H
-quinolin-2-ones: A Novel Class of KDR Kinase Inhibitors
. The Journal of Organic Chemistry 70:7, pages 2555-2567.
Crossref
Crossref
Jacek J. Slon-Usakiewicz, Jin-Rui Dai, William Ng, J. Estelle Foster, Eugen Deretey, Leticia Toledo-Sherman, Peter R. Redden, Andrew Pasternak & Neil Reid. (2005) Global Kinase Screening. Applications of Frontal Affinity Chromatography Coupled to Mass Spectrometry in Drug Discovery. Analytical Chemistry 77:5, pages 1268-1274.
Crossref
Crossref
Katherine R. Calvo, Lance A. Liotta & Emanuel F. Petricoin. (2005) Clinical Proteomics: From Biomarker Discovery and Cell Signaling Profiles to Individualized Personal Therapy. Bioscience Reports 25:1-2, pages 107-125.
Crossref
Crossref
Hwei-Ru Tsou, Elsebe G. Overbeek-Klumpers, William A. Hallett, Marvin F. Reich, M. Brawner Floyd, Bernard D. Johnson, Ronald S. Michalak, Ramaswamy Nilakantan, Carolyn Discafani, Jonathan Golas, Sridhar K. Rabindran, Ru Shen, Xiaoqing Shi, Yu-Fen Wang, Janis Upeslacis & Allan Wissner. (2005) Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity. Journal of Medicinal Chemistry 48:4, pages 1107-1131.
Crossref
Crossref
Jung-Im Huh, Alfonso Calvo, Jeffrey Stafford, Mui Cheung, Rakesh Kumar, Deborah Philp, Hynda K Kleinman & Jeffrey E Green. (2004) Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms. Oncogene 24:5, pages 790-800.
Crossref
Crossref
Helen C Swaisland, Malcolm Ranson, Robert P Smith, Joanna Leadbetter, Alison Laight, David McKillop & Martin J Wild. (2005) Pharmacokinetic Drug Interactions of Gefitinib with Rifampicin, Itraconazole and Metoprolol. Clinical Pharmacokinetics 44:10, pages 1067-1081.
Crossref
Crossref
Beverly A. Teicher. 2005. Advances in Targeted Cancer Therapy. Advances in Targeted Cancer Therapy
43
66
.
M. Gaßel, C. Breitenlechner, S. Herrero, R. Engh & D. Bossemeyer. 2005. Inhibitors of Protein Kinases and Protein Phosphates. Inhibitors of Protein Kinases and Protein Phosphates
85
124
.
Soji Kakiuchi, Yataro Daigo, Nobuhisa Ishikawa, Chiyuki Furukawa, Tatsuhiko Tsunoda, Seiji Yano, Kazuhiko Nakagawa, Takashi Tsuruo, Nobuoki Kohno, Masahiro Fukuoka, Saburo Sone & Yusuke Nakamura. (2004) Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839). Human Molecular Genetics 13:24, pages 3029-3043.
Crossref
Crossref
Flavio F. Solca, Anke Baum, Elke Langkopf, Georg Dahmann, Karl-Heinz Heider, Frank Himmelsbach & Jacques C. A. van Meel. (2004) Inhibition of Epidermal Growth Factor Receptor Activity by Two Pyrimidopyrimidine Derivatives. Journal of Pharmacology and Experimental Therapeutics 311:2, pages 502-509.
Crossref
Crossref
Tappei Takada, H. Markus Weiss, Olivier Kretz, Gerhard Gross & Yuichi Sugiyama. (2004) HEPATIC TRANSPORT OF PKI166, AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR OF THE PYRROLO-PYRIMIDINE CLASS, AND ITS MAIN METABOLITE, ACU154. Drug Metabolism and Disposition 32:11, pages 1272-1278.
Crossref
Crossref
Nguyen-Hai Nam, Sungsoo Lee, Guofeng Ye, Gongqin Sun & Keykavous Parang. (2004) ATP-phosphopeptide conjugates as inhibitors of Src tyrosine kinases. Bioorganic & Medicinal Chemistry 12:22, pages 5753-5766.
Crossref
Crossref
Innocenzo Sammarco, Gabriele Capurso, Luigi Coppola, Antonio Paniccià Bonifazi, Sara Cassetta, Gianfranco Delle Fave, Alessandro Carrara, Giovanni Battista Grassi, Pellegrino Rossi, Claudio Sette & Raffaele Geremia. (2004) Expression of the proto-oncogene c-KIT in normal and tumor tissues from colorectal carcinoma patients. International Journal of Colorectal Disease 19:6, pages 545-553.
Crossref
Crossref
Peter Traxler, Peter R. Allegrini, Ralf Brandt, Josef Brueggen, Robert Cozens, Doriano Fabbro, Konstantina Grosios, Heidi A. Lane, Paul McSheehy, Jürgen Mestan, Thomas Meyer, Careen Tang, Markus Wartmann, Jeanette Wood & Giorgio Caravatti. (2004) AEE788. Cancer Research 64:14, pages 4931-4941.
Crossref
Crossref
Markus M. Vögtle & Andreas L. Marzinzik. (2004) Synthetic Approaches Towards Quinazolines, Quinazolinones and Quinazolinediones on Solid Phase. QSAR & Combinatorial Science 23:6, pages 440-459.
Crossref
Crossref
Csilla Özvegy-Laczka, Tamás Hegedűs, György Várady, Olga Ujhelly, John D. Schuetz, András Váradi, György Kéri, László Őrfi, Katalin Német & Balázs Sarkadi. (2004) High-Affinity Interaction of Tyrosine Kinase Inhibitors with the ABCG2 Multidrug Transporter. Molecular Pharmacology 65:6, pages 1485-1495.
Crossref
Crossref
Monica L. GuzmanCraig T. Jordan. (2017) Considerations for Targeting Malignant Stem Cells in Leukemia. Cancer Control 11:2, pages 97-104.
Crossref
Crossref
Kerstin Nagel-Wolfrum, Claudia Buerger, Ilka Wittig, Karin Butz, Felix Hoppe-Seyler & Bernd Groner. (2004) The Interaction of Specific Peptide Aptamers With the DNA Binding Domain and the Dimerization Domain of the Transcription Factor Stat3 Inhibits Transactivation and Induces Apoptosis in Tumor Cells. Molecular Cancer Research 2:3, pages 170-182.
Crossref
Crossref
Thomas HolbroNancy E. Hynes. (2004) ErbB Receptors: Directing Key Signaling Networks Throughout Life. Annual Review of Pharmacology and Toxicology 44:1, pages 195-217.
Crossref
Crossref
Laura S. Ward & Lígia V.M. Assumpção. (2004) Câncer diferenciado da tiróide: fatores prognósticos e tratamento. Arquivos Brasileiros de Endocrinologia & Metabologia 48:1, pages 126-136.
Crossref
Crossref
Ian M Adcock & Gaetano Caramori. (2004) Kinase Targets and Inhibitors for the Treatment of Airway Inflammatory Diseases. BioDrugs 18:3, pages 167-180.
Crossref
Crossref
Russell C. Cattley & Bert R. Radinsky. (2016) Cancer Therapeutics: Understanding the Mechanism of Action. Toxicologic Pathology 32:1_suppl, pages 116-121.
Crossref
Crossref
Masha Y. Niv, Hila Rubin, Jacob Cohen, Lilia Tsirulnikov, Tamar Licht, Adi Peretzman-Shemer, Einat Cna'an, Alexander Tartakovsky, Ilan Stein, Shira Albeck, Irina Weinstein, Mirela Goldenberg-Furmanov, Dror Tobi, Einat Cohen, Morris Laster, Shmuel A. Ben-Sasson & Hadas Reuveni. (2004) Sequence-based Design of Kinase Inhibitors Applicable for Therapeutics and Target Identification. Journal of Biological Chemistry 279:2, pages 1242-1255.
Crossref
Crossref
Jeffrey T. Kuethe, Audrey Wong & Ian W. Davies. (2003)
Rapid and Efficient Synthesis of 1
H
-Indol-2-yl-1
H
-quinolin-2-ones
. Organic Letters 5:21, pages 3975-3978.
Crossref
Crossref